News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
200 years of The Lancet. – The Lancet
Photo from The Lancet/Twitter
Oct 8, 2023, 18:01

200 years of The Lancet. – The Lancet

The Lancet shared on X/Twitter:

“200 years of publishing practice-changing research.
200 years of being ‘more than a medical journal’.
200 years of moving the dial on health.
200 years of The Lancet.

Read the special anniversary issue here.”

Source: The Lancet/Twitter

anniversary cancer OncoDaily Oncology The Lancet
Special Coverage
Blog
May 30, 2025, 16:07
Wafaa M Rashed: Future African Leader Spotlight - Kedir Hassen
Oncolibrary
May 30, 2025, 16:01
Oncoviruses and Their Role in Human Cancer: Types, and Global Impact
Blog
May 30, 2025, 15:45
Mamtha Balla and Supriya Peshin Call on Heme-Onc Fellows for Education Survey During ASCO 2025
Blog
May 30, 2025, 15:37
Elvina Almuradova: MSKCC Study Sheds Light on Treatment of HER2+ Node-Negative Breast Cancer
Blog
May 30, 2025, 15:27
Noha Soror: Sign up for Conquer Cancer, the ASCO Foundation Office Hours at the ASCO Annual Meeting
Blog
May 30, 2025, 15:24
The Dorcas Cancer Foundation participated in the St. Jude Children's Research Hospital Global Alliance SSA Regional Meeting
Blog
May 30, 2025, 15:13
Vivek Subbiah: Exhilarating Discussions with Erika Hamilton at the ASCO 2025 Annual Meeting
Blog
May 30, 2025, 15:11
Amer Zeidan Invites to Join ASCO 2025 PER Symposium on Acute Myeloid Leukemia
Blog
May 30, 2025, 15:06
Shilpa Gupta: Excited to connect with friends and colleagues, share our work at ASCO 2025
Blog
May 30, 2025, 15:00
Fatima Cardoso Calls For a Comprehensive European Strategy on Genetic and Genomic Testing for Breast Cancer - TBCT
Dialogues
May 30, 2025, 14:55
Episode14 with Michael Meister – Cancer Through My Eyes
Drugs
May 30, 2025, 14:45
Supriya Peshin: FDA Approved Retifanlimab Combination for 1st Line Treatment of Advanced SCAC